Catheter ablation does not improve quality of life related to atrial fibrillation
Catheter ablation is widely performed to treat atrial fibrillation (AF) but evidence on whether the procedure improves patients’ quality of life related to AF is lacking. In the PVI-SHAM-AF trial, both catheter ablation and a sham intervention improved AF-related...
New research shows transcatheter repair reduces death and heart failure hospitalisation in severe tricuspid regurgitation vs. medical therapy alone
ESC CONGRESS 2026 Severe tricuspid regurgitation is a heart valve disorder associated with debilitating symptoms and increased risk of death. The TRIC-I-HF trial studied transcatheter valve repair plus medical therapy vs. medical therapy alone in patients with severe...
Record-breaking ESC Congress 2026 puts new life-saving cardiovascular science in the spotlight
A total of 33,800 healthcare professionals from 170 countries participated in ESC Congress 2026, the largest ever flagship meeting of the European Society of Cardiology (ESC). This year’s congress took place in Munich, Germany, and focused on the spotlight theme...
Implantable cardioverter-defibrillators may benefit certain younger patients with mild–moderate heart dysfunction
Key takeaways Sudden cardiac death occurs in patients with heart failure and left ventricular ejection fraction (LVEF) greater than 35% but they are not currently eligible for an implantable cardioverter-defibrillator (ICD). The CMR GUIDE trial evaluated whether an...
New global definition of myocardial infarction aims to improve diagnosis, treatment and patient understanding
Munich, Germany – 28 August 2026: When a myocardial infarction, such as a heart attack, occurs, being able to classify its type can improve diagnosis and treatment. For the first time, a universal definition of myocardial infarction has been developed and published by...
Implantable cardioverter-defibrillators may benefit certain younger patients with mild–heart dysfunction
Munich, Germany – 28 August 2026: An implantable cardioverter-defibrillator did not improve the primary endpoint overall in the CMR GUIDE trial but younger patients appeared to benefit, according to results presented in a Hot Line session today at ESC Congress 20261 and...
ESC Congress 2026 Heart, body and mind – the first ESC Guidelines highlight the many benefits of cardiac rehabilitation
Key takeaways The first dedicated ESC Guidelines on cardiac rehabilitation have been published today in the European Heart Journal. The new guidelines highlight how cardiac rehabilitation can improve quality of life, physical fitness, confidence and mental...
ESMO Gastrointestinal Cancers Congress 2026
Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery Munich, Germany – A blood test may help identify which patients with colorectal cancer that has spread to the liver are most...
Romanian Robotic & Metabolic Surgery Days 2026
Dear Colleagues, It is our great pleasure to invite you to the Romanian Robotic & Metabolic Surgery Days 2026, held under the theme “Bringing Better Care to All.” It became a tradition for the two professional associations, RAES and RSMS to organize successful...
Blood Test May Help Identify Which Colorectal Cancer Patients with Liver Metastases Are Most Likely to Benefit from Chemotherapy After Surgery
Date: 03 Jul 2026 Munich, Germany – A blood test may help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from chemotherapy after surgery, according to research presented today at the ESMO Gastrointestinal Cancers...
ESC Congress 2026: Transforming innovative ideas into clinical reality
Key takeaways The world's leading cardiology experts will convene in Munich for ESC Congress 2026. The event takes place from 28 to 31 August, with the press programme beginning on 27 August. This year’s spotlight on artificial intelligence will explore the potential...
Common food preservatives linked to high blood pressure and heart disease
Key takeaways The study of 112,395 people includes a detailed analysis of diet and food ingredients. Researchers found eight preservative food additives linked to high blood pressure or cardiovascular disease. The highest risks were in people who ate the most...
Experts call for women’s heart centres to tackle inequality in diagnosis & care
Key takeaways: Cardiovascular disease is the leading cause of death in women. Women are more likely to have undiagnosed and untreated cardiovascular disease. Dedicated women's heart centres are needed to improve diagnosis, treatment and care. Sophia Antipolis,...
ESMO Breast Cancer 2026 – Precision Oncology, Molecular Monitoring and the Evolving Paradigm of Survivorship Care
The scientific programme of ESMO Breast Cancer 2026 highlighted the accelerating integration of precision oncology into breast cancer prevention, disease monitoring, and survivorship care. Across sessions dedicated to early detection, translational research, and early...
National Study Examines Genetic Testing to Inform Follow-up Care for Cancer Survivors A study presented at the ESMO Breast Cancer 2026 congress
Date: 07 May 2026 BERLIN, Germany – Hundreds of thousands of people diagnosed with cancer are still alive today but were never genetically tested, either because testing was not available or was not routinely offered at the time of their diagnosis. These patients are...
Opening Ceremony of ESMO Breast Cancer 2026 Sets the Tone for Innovation and Global Collaboration
The ESMO Breast Cancer 2026 officially commenced on Wednesday, May 6, with a distinguished opening ceremony and award lecture that underscored the rapid pace of scientific advancement and the critical role of international collaboration in improving breast cancer...
Improving cardiovascular risk prediction in Latin America and the Caribbean: SCORE2-LAC
Key takeaways Cardiovascular disease risk prediction models are used to identify people who benefit most from preventive action. The Systematic COronary Risk Evaluation 2 (SCORE2) risk prediction system implemented in ESC Guidelines is based on data from European...
New data on effective cardiac resynchronisation in patients with heart failure
14 April 2026: Left bundle branch area pacing was found to be an effective and practical strategy for cardiac resynchronisation, according to a Late-Breaking Science presentation at EHRA 2026,1 the annual congress of the European Heart Rhythm Association (EHRA), a...
European Lung Cancer Congress 2026 – Significant Advances in the Management of Lung Cancer
Between March 25–28, 2026, in Copenhagen, the European Lung Cancer Congress 2026 took place, one of the most important scientific events dedicated to thoracic oncology. The congress brought together leading experts in medical oncology, pulmonology, thoracic surgery,...
EHRA 2026: Shining a light on arrhythmia management
The global community of heart rhythm specialists will unite in Paris from 12 to 14 April 2026 for EHRA 2026, the annual congress of the European Heart Rhythm Association (EHRA), a branch of the European Society of Cardiology (ESC). “With around 1 in 3−5 five people...
European Lung Cancer Congress 2026 Population-based lung cancer screening can reduce mortality in people who have never smoked, study shows in China
COPENHAGEN, Denmark, 27 March 2026 – New evidence from a Chinese cohort presented today at the European Lung Cancer Congress (ELCC) 2026 shows that onetime lowdose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in a...
The Power of the Heart Team: Advancing Acute Cardiovascular Care Together ESC Acute CardioVascular Care 2026 to take place in Lisbon
Key takeaways ESC Acute CardioVascular Care 2026 (#ACVC26), the annual meeting for acute cardiovascular care professionals, will take place 20–21 March 2026 in Lisbon, Portugal. The two-day program features nearly 100 scientific sessions covering the full spectrum of...
ESC launches guidelines for patients to empower women with cardiovascular disease to make informed pregnancy health decisions
Key takeaways A new patient version of ESC Guidelines on pregnancy is being published on International Women’s Day to empower women living with cardiovascular disease to make informed decisions about pregnancy and birth and support shared decision making with...
Interview with Dr. Christopher M. Kramer, MD President of the American College of Cardiology. Lack of awareness is a major challenge in addressing environmental risk factors
The American College of Cardiology (ACC) is the global leader in transforming cardiovascular care and improving heart health for all. Since 1949, the ACC has served as the preeminent source of professional medical education for the entire cardiovascular care team,...